Immunochemotherapy for Richter syndrome: current insights

Richter syndrome (RS) is recognized as the development of a secondary and aggressive lymphoma during the clinical course of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Most of such histological transformations are from RS to diffuse large B-cell lymphoma (DLBCL-RS, 90%) and Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Puła, Bartosz, Salomon-Perzyński, Aleksander, Prochorec-Sobieszek, Monika, Jamroziak, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368420/
https://www.ncbi.nlm.nih.gov/pubmed/30788335
http://dx.doi.org/10.2147/ITT.S167456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368420/
https://www.ncbi.nlm.nih.gov/pubmed/30788335
http://dx.doi.org/10.2147/ITT.S167456

Ejemplares similares